Caitlin Bowen, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Collagen Type III | 1 | 2020 | 91 | 0.680 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2020 | 92 | 0.640 |
Why?
|
| Aortic Rupture | 1 | 2020 | 315 | 0.550 |
Why?
|
| Women | 1 | 2018 | 225 | 0.540 |
Why?
|
| Cadherins | 3 | 2016 | 898 | 0.540 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 1477 | 0.440 |
Why?
|
| Self Concept | 1 | 2018 | 1041 | 0.410 |
Why?
|
| Loeys-Dietz Syndrome | 2 | 2022 | 40 | 0.390 |
Why?
|
| Schools, Medical | 1 | 2018 | 877 | 0.390 |
Why?
|
| Aortic Valve | 3 | 2016 | 1950 | 0.370 |
Why?
|
| Extracellular Matrix | 2 | 2016 | 1723 | 0.370 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 3709 | 0.330 |
Why?
|
| Marfan Syndrome | 2 | 2021 | 236 | 0.300 |
Why?
|
| Cell Movement | 3 | 2016 | 5201 | 0.240 |
Why?
|
| Sex Factors | 1 | 2018 | 10505 | 0.230 |
Why?
|
| Biomedical Research | 1 | 2018 | 3417 | 0.210 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2022 | 72 | 0.190 |
Why?
|
| Patellar Ligament | 1 | 2022 | 64 | 0.190 |
Why?
|
| Premedication | 1 | 2019 | 247 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2020 | 473 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2020 | 477 | 0.150 |
Why?
|
| Sex Ratio | 1 | 2018 | 107 | 0.150 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2021 | 537 | 0.150 |
Why?
|
| Asparaginase | 1 | 2019 | 240 | 0.150 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2016 | 234 | 0.150 |
Why?
|
| Drug Substitution | 1 | 2019 | 288 | 0.130 |
Why?
|
| Calcinosis | 2 | 2016 | 1467 | 0.130 |
Why?
|
| Endocardial Cushions | 1 | 2015 | 12 | 0.130 |
Why?
|
| Oxytocin | 1 | 2019 | 401 | 0.120 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2021 | 695 | 0.120 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2019 | 515 | 0.120 |
Why?
|
| Chickens | 1 | 2015 | 860 | 0.110 |
Why?
|
| Drug Monitoring | 1 | 2019 | 960 | 0.110 |
Why?
|
| Aortic Valve Stenosis | 2 | 2016 | 2002 | 0.100 |
Why?
|
| Heart Valves | 1 | 2013 | 284 | 0.100 |
Why?
|
| Cell Polarity | 1 | 2015 | 638 | 0.100 |
Why?
|
| Career Choice | 1 | 2018 | 752 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 9518 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2015 | 740 | 0.100 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2021 | 1426 | 0.090 |
Why?
|
| Drug Hypersensitivity | 1 | 2019 | 915 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2022 | 18125 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1890 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 2359 | 0.070 |
Why?
|
| Students, Medical | 1 | 2019 | 1927 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 22006 | 0.060 |
Why?
|
| Swine | 1 | 2015 | 5892 | 0.060 |
Why?
|
| Infant | 2 | 2024 | 36054 | 0.060 |
Why?
|
| Mice | 4 | 2022 | 81107 | 0.060 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 1634 | 0.050 |
Why?
|
| Animals | 6 | 2022 | 167777 | 0.050 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2022 | 461 | 0.040 |
Why?
|
| Hydralazine | 1 | 2019 | 34 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2021 | 895 | 0.040 |
Why?
|
| Tendons | 1 | 2022 | 552 | 0.040 |
Why?
|
| Propranolol | 1 | 2019 | 489 | 0.040 |
Why?
|
| Lactation | 1 | 2019 | 397 | 0.030 |
Why?
|
| Humans | 8 | 2024 | 758381 | 0.030 |
Why?
|
| Stress Fibers | 1 | 2016 | 55 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2019 | 640 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13591 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 145 | 0.030 |
Why?
|
| Mutation | 1 | 2020 | 29915 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2263 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2016 | 277 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2016 | 280 | 0.030 |
Why?
|
| Focus Groups | 1 | 2019 | 1382 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2019 | 1240 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2013 | 981 | 0.020 |
Why?
|
| Aorta | 1 | 2019 | 2037 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2021 | 22031 | 0.020 |
Why?
|
| Wound Healing | 1 | 2022 | 2783 | 0.020 |
Why?
|
| United States | 1 | 2018 | 72140 | 0.020 |
Why?
|
| Female | 5 | 2021 | 390316 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2016 | 3090 | 0.020 |
Why?
|
| Stents | 1 | 2021 | 3162 | 0.020 |
Why?
|
| Male | 4 | 2021 | 358742 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2019 | 2976 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 2907 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2016 | 4114 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10112 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 3990 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 58808 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 5629 | 0.010 |
Why?
|
| Child | 2 | 2021 | 79813 | 0.010 |
Why?
|
| Adolescent | 2 | 2021 | 87888 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2021 | 80170 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7583 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 18942 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 12760 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29558 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16534 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15785 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39060 | 0.010 |
Why?
|
| Pregnancy | 1 | 2019 | 29742 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11471 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 42058 | 0.010 |
Why?
|
| Adult | 2 | 2021 | 219916 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 54136 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17768 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 23341 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 168217 | 0.000 |
Why?
|
| Middle Aged | 1 | 2021 | 219560 | 0.000 |
Why?
|